Organisation paid for research Program year 2025 Source: CMS Open Payments

Academy of Diabetes Thyroid and Endocrine, PA

Neither a doctor nor a teaching hospital

Research payments

$265,910

380 payments

Through program year 2025, Academy of Diabetes Thyroid and Endocrine, PA is reported as receiving $265,910 in research payments, across 380 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $37,714 2
2024 Research $9,232 4
2023 Research $10,276 102
2022 Research $7,106 37
2021 Research $29,185 86
2020 Research $117,462 131
2019 Research $54,934 18

Breakdown

Who paid Research payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $184,321 7 payments
  2. Novo Nordisk AS $59,748 358 payments
  3. Corcept Therapeutics $17,842 14 payments
  4. Alexion Pharmaceuticals, Inc. $3,999 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease $140,693 4 payments
  2. Nn9535-4321 $58,581 310 payments
  3. A Phase IIb Randomized Double blind Placebo controlled and Open label Active Comparator Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Adults with Type 2 Diabetes Mellitus $33,716 1 payment
  4. Cort125134-456 $15,054 11 payments
  5. A Phase 2b Multicenter Randomised Double blind Placebo controlled Study of Verinurad and Allopurinol in Patients with Chronic Kidney Disease and Hyperuricemia $9,912 2 payments
  6. Eneboparatide - Calypso study which is a pivotal phase 3 study investigational therapeutic peptide with a novel mechanism of action for hypoparathyroidism $3,999 1 payment
  7. Cort125134-452 $2,039 2 payments
  8. Ex6018-4758 $1,167 48 payments
  9. Cort125134-455 $749 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record